Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphatic Metastasis 1 Lung Neoplasms 1

Interventions

pembrolizumab 1 Technetium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lymphatic Metastasis × Technetium × Clear all

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed

Lung Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡